Treatment of Vaginal Cancer with Oligo-Metastatic Disease at Presentation

Vaginal cancer presenting with limited distant (oligo-) metastatic spread at initial diagnosis is a distinct clinical situation. Rather than defaulting to purely palliative care, patients in this setting should be evaluated for curative-intent management.

Clinical Scenario

Patients with limited distant (oligo-) metastatic disease at presentation should be considered for treatment with curative intent.

Treatment Approach

Management follows a curative-intent strategy that addresses both the primary tumour and each site of limited metastatic spread, with the approach to individual sites guided by location and clinical circumstances.

The complete regimen — including specific therapies, sequencing, and site-specific options — is detailed in the full structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.radonc.2023.109662

Patients with limited distant (oligo-) metastatic disease at presentation should be considered for treatment with curative intent.

Patients with oligo-metastatic disease at presentation may be treated with definitive chemoradiotherapy including brachytherapy, in combination with systemic therapy [IV, C].

Treatment of oligometastatic sites depends on the site of disease and symptoms and may consist of (stereotactic) radiotherapy, or surgical resection and radiofrequency ablation in selected cases [IV, C].

View source ↗